TherapeuticsMD, Inc.TXMDNASDAQ

Revenue (LTM)

$2M

+35.3% YoY

Net Income (LTM)

$-2M

+78.8% YoY

Free Cash Flow

$732000

Revenue CAGR (5Y)

-59.4%

Marginsimproving

FCFTurned positive

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	65	3↓96.0%	70↑2619.1%	1↓98.1%	2↑35.3%
Gross Profit	49	1↓97.6%	69↑5755.3%	1↓98.1%	2↑35.3%
Operating Income	-156	-80↑48.8%	1↑101.5%	-9↓815.6%	-5↑44.2%
Net Income	-184	-172↑6.1%	112↑165.0%	-10↓109.2%	-2↑78.8%
EBITDA	-153	-71↑53.8%	12↑116.7%	-8↓168.1%	-3↑63.1%
EPS Diluted	-38.58	-25.83↑33.0%	-10.35↑59.9%	-0.74↑92.9%	-0.19↑74.3%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	80	65↓19.4%	38↓41.4%	4↓88.6%	5↑16.9%
Total Current Assets	128	119↓7.0%	55↓53.7%	12↓78.7%	10↓15.9%
Total Assets	182	169↓6.7%	90↓46.6%	43↓52.1%	39↓10.4%
Total Current Liabilities	59	253↑326.9%	47↓81.5%	7↓85.4%	5↓24.6%
Total Liabilities	306	263↓13.9%	55↓79.0%	14↓74.7%	11↓18.3%
Total Equity	-124	-94↑24.5%	35↑137.5%	29↓16.7%	27↓6.5%
Total Debt	249	198↓20.5%	9↓95.6%	8↓8.6%	7↓10.4%
Net Debt	168	133↓21.0%	-29↓122.1%	4↑112.5%	2↓42.5%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-159	-148↑7.3%	-4↑97.2%	-48↓1080.5%	1↑101.5%
Capital Expenditure	-2	-0↑97.9%	-0↓944.1%	48↑13660.8%	0
Free Cash Flow	-161	-148↑8.2%	-4↑97.0%	0	1
Stock-Based Comp	11	0	12	0	0
Net Change in Cash	-80	-16↑80.6%	-16↓1.5%	-45↓184.7%	1↑101.6%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance